BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KK3910 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of KK3910\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06823947-568@assetmemo.bio
DTSTAMP:20261121T005837Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:KK3910: Phase 1 readout est. (NCT06823947)
DESCRIPTION:KK3910\, phase 1\, Hypertension.\nStudy: Study of KK3910 in Hea
 lthy Volunteers and Patients With Essential Hypertension\nEstimated primar
 y completion: December 2027. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/kk3910#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT06823947
URL:https://assetmemo.bio/drug/kk3910#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
